Autoantibodies associated with diseases of the CNS: new developments and future challenges (Q37903490)

25 August 2017

1 reference

title

Autoantibodies associated with diseases of the CNS: new developments and future challenges (English)

1 reference

25 August 2017

1 reference

Sarosh R Irani

3

0 references

Angela Vincent

series ordinal

1

object named as

Angela Vincent

1 reference

25 August 2017

Christian G Bien

2

1 reference

PubMed ID

21777830

25 August 2017

Patrick Waters

series ordinal

4

1 reference

25 August 2017

1 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

10

1 reference

25 August 2017

8

1 reference

25 August 2017

759-772

1 reference

Autoimmune channelopathies and related neurological disorders

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Paraneoplastic syndromes of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Autoimmune channelopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

"Limbic encephalitis" and its association with carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Separation of Domain Contacts Is Required for Heterotetrameric Assembly of Functional NMDA Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Multiple molecular interactions determine the clustering of Caspr2 and Kv1 channels in myelinated axons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Potassium channel antibodies in two patients with reversible limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Clinical spectrum of voltage-gated potassium channel autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Serum antibodies in epilepsy and seizure-associated disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Immunotherapy responsive startle with antibodies to voltage gated potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Hypothermia in VGKC antibody-associated limbic encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Autoantibodies in patients with gut motility disorders and enteric neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Non-paraneoplastic limbic encephalitis associated with antibodies to potassium channels leading to bilateral hippocampal sclerosis in a pre-pubertal girl

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Limbic encephalitis in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Voltage‐gated potassium channel antibodies in limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

IMMUNOTHERAPY-RESPONSIVE SEIZURE-LIKE EPISODES WITH POTASSIUM CHANNEL ANTIBODIES

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Improvement of non-paraneoplastic voltage-gated potassium channel antibody-associated limbic encephalitis without immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Extensive and temporally ungraded retrograde amnesia in encephalitis associated with antibodies to voltage-gated potassium channels.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Antibodies to voltage-gated potassium and calcium channels in epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

The expanding clinical profile of anti-AMPA receptor encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Stiff person syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Immune mediated chorea encephalopathy syndrome in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

The distinctive movement disorder of ovarian teratoma-associated encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

A patient with encephalitis associated with NMDA receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Case records of the Massachusetts General Hospital. Case 26-2008. A 26-year-old woman with headache and behavioral changes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Anti-N-methyl-D-aspartate-receptor encephalitis in a four-year-old girl

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Anti-NMDA receptor encephalitis: a video case report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Morvan's fibrillary chorea: remission after plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Morvan's syndrome associated with voltage-gated K+ channel antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Neurophysiologic studies in Morvan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

fasciculations, autonomic symptoms and limbic encephalitis: a thymoma-associated Morvan's-like syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Functional imaging correlates of fronto-temporal dysfunction in Morvan's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Caspr2 antibodies in patients with thymomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

The stiff man and stiff man plus syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Stiff man syndrome and related conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Disease-relevant autoantibodies in first episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Cognition and immunity; antibody impairs memory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Increased permeability of blood–brain barrier on the hippocampus of a murine model of senescence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

Anti-NMDA receptor encephalitis with atypical brain changes on MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

VGKC antibodies in pediatric encephalitis presenting with status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

A new cause of limbic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970096-5

7 January 2021

10.1016/S1474-4422(11)70096-5

Identifiers

DOI

1 reference

release_j4kf334oq5c3zekbvzfnxw2urm

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j4kf334oq5c3zekbvzfnxw2urm

24 November 2022

mapped directly with Wikidata item

PubMed ID

21777830

1 reference

PubMed ID

21777830